Publication | Open Access

Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial

Regenerative MedicineCell TherapyTransplantationMarrow TransplantationPlacebo-controlled Phase 3Stem Cell TransplantationImmunologyOral Ixazomib MaintenanceMedicineCell Transplantation